| Closed |
SWOG-9431 |
Ancillary to SWOG-Coordinated Melanoma Trials |
11/15/1996 |
12/15/2005 |
|
|
Published
|
| Closed |
SWOG-8947 |
ANCILLARY: Central Lymphoma Serum Repository Protocol |
4/15/1990 |
|
|
|
|
| Closed |
SWOG-8819 |
ANCILLARY: Central Lymphoma Tissue Repository |
2/15/1989 |
|
|
|
Published
|
| Closed |
SWOG-9245 |
ANCILLARY: Central Lymphoma Tissue Repository for Relapsed or Recurrent Disease |
3/15/1993 |
|
|
|
|
| Closed |
S0307A |
ANCILLARY: S0307 Companion Study |
10/1/2008 |
2/1/2010 |
0% |
|
|
| Closed |
S9719 |
ANCILLARY: Incidence of clonal hematopoiesis in marrow (when available), PBPC products and PB. |
10/15/1997 |
2/1/2001 |
13% |
|
|
| Closed |
S0916 |
Anti-CCR2 Ab for Bone Metastases |
3/1/2010 |
3/15/2011 |
98% |
|
|
| Closed |
S9703 |
Antibiotic eradication of H. pylori and, if needed, CHOP + RT |
9/15/1997 |
3/1/1999 |
0% |
|
|
| Closed |
SWOG-7940/44 |
Appendix VI-SWOG-7940, Evaluation of AZQ in Metastatic Adenocarcinoma of the Large Bowel |
9/23/1980 |
6/4/1981 |
|
|
|
| Closed |
SWOG-7940/45 |
Appendix VI-SWOG-7940, Evaluation of AZQ in Metastatic Adenocarcinoma of the Large Bowel |
6/4/1981 |
5/5/1982 |
|
|
|
| Open |
S2010 |
ASPEN |
1/17/2023 |
|
92% |
|
|
| Closed |
S0020 |
ATG for MDS |
8/15/2001 |
5/15/2003 |
16% |
|
|
| Closed |
SWOG-9300 |
ATRA/IFN vs ATRA/HU for New CML |
10/1/1993 |
12/1/1999 |
95% |
|
|
| Closed |
SWOG-8309 |
Autologous Marrow Transplantation for the Treatment of Non-Hodgin's Lymphoma |
10/3/1984 |
5/1/1989 |
|
|
Published
|
| Closed |
SWOG-9328 (ECOG-S9328) |
Autologous Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Beyond First Remission: A Randomized Trial of Post-Transplant Therapy with Interleukin-2 Versus Observation Phase III |
7/1/1994 |
6/1/1996 |
4% |
|
|
| Closed |
S0802 |
AVE0005 in E-SCLC, Randomized Ph II |
5/15/2009 |
3/1/2012 |
100% |
|
Published
|
| Closed |
S0509 |
AZD2171/Malignant Pleural Mesothelioma |
11/1/2005 |
4/1/2008 |
100% |
|
Published
|
| Closed |
SWOG-8207 |
AZQ in Advanced Renal Cell Carcinoma |
7/9/1982 |
3/16/1984 |
|
|
Published
|
| Closed |
S0316 |
Barriers to Accrual |
8/1/2004 |
6/15/2008 |
97% |
|
Published
|
| Closed |
S0438 |
BAY 43-9006 + CCI-779 or R115777 in Metastatic Melanoma |
8/1/2007 |
11/15/2009 |
91% |
|
Published
|
